During the past decade, Basavatarakam Indo-American Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Basavatarakam Indo-American Hospital" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Johnson & Johnson Private Limited" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Merck KGaA, Darmstadt, Germany" with 2 trials sponsored and "Agennix" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Basavatarakam Indo-American Hospital" #1 collaborator was "Merck Ltd., India" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Basavatarakam Indo-American Hospital" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Leukemia, Lymphocytic, Chronic, B-Cell" (2 trials), "Lymphoma, Mantle-Cell" (2 trials), "Breast Cancer" (1 trials) and "Carcinoma, Squamous Cell" (1 trials). Many other conditions were trialed in "Basavatarakam Indo-American Hospital" in a lesser frequency.

Most popular intervention types in "Basavatarakam Indo-American Hospital" are "Drug" (13 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (2 trials), "Cetuximab" (2 trials), "Placebo" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Basavatarakam Indo-American Hospital" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Basavatarakam Indo-American Hospital". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Basavatarakam Indo-American Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Basavatarakam Indo-American Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".